Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07328698Recruiting
Randomised, single-blind trial of ozonated oil in surgical site infection (SSI) (2 arms), sponsored by Niğde Ömer Halisdemir University. Primary endpoint: Composite Wound Inflammation Score at Day 3. Started Feb 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07328698.